Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia

Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia

Bibliographic Details
Main Authors: J Dretzke, P Barton, B Kaambwa, M Connock, O Uthman, S Bayliss, C Meads
Format: Article
Language:English
Published: NIHR Journals Library 2010-10-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta14suppl2/03
id doaj-c0d1ffcb96ed4c74907cab7a4c0a5f44
record_format Article
spelling doaj-c0d1ffcb96ed4c74907cab7a4c0a5f442020-11-24T23:40:14ZengNIHR Journals LibraryHealth Technology Assessment1366-52782010-10-0114Suppl. 210.3310/hta14suppl2/03Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemiaJ Dretzke0P BartonB KaambwaM ConnockO UthmanS BaylissC MeadsUnit of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UKhttps://doi.org/10.3310/hta14suppl2/03
collection DOAJ
language English
format Article
sources DOAJ
author J Dretzke
P Barton
B Kaambwa
M Connock
O Uthman
S Bayliss
C Meads
spellingShingle J Dretzke
P Barton
B Kaambwa
M Connock
O Uthman
S Bayliss
C Meads
Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
Health Technology Assessment
author_facet J Dretzke
P Barton
B Kaambwa
M Connock
O Uthman
S Bayliss
C Meads
author_sort J Dretzke
title Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
title_short Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
title_full Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
title_fullStr Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
title_full_unstemmed Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
title_sort rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
publisher NIHR Journals Library
series Health Technology Assessment
issn 1366-5278
publishDate 2010-10-01
url https://doi.org/10.3310/hta14suppl2/03
work_keys_str_mv AT jdretzke rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia
AT pbarton rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia
AT bkaambwa rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia
AT mconnock rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia
AT outhman rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia
AT sbayliss rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia
AT cmeads rituximabforthetreatmentofrelapsedrefractorychroniclymphocyticleukaemia
_version_ 1725510478580416512

Similar Items